Published in Drug Law Weekly, January 26th, 2010
"Identifying therapies that effectively eliminate CLL cells and lack immunesuppression represent an exciting new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.